Phase 2 N=144 Olanzapine for Nausea After Surgery
Postoperative Nausea and Vomiting
Primary: Number of Participants With Nausea and/or Vomiting — 10; 26 Participants — p=0.003
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=200 Aprepitant for Post-operative Nausea
Postoperative Nausea
Primary: Post-operative Nausea and Vomiting
N/A N=180 Prevention of Postoperative Nausea and Vomiting (PONV) in Surgical Patients
Postoperative Nausea and Vomiting
Primary: Incidence of Postoperative Nausea and Vomiting — 34.4; 29.8; 12.5; 7 percentage of participants — p=>0.76
Phase 4 N=54 Effectiveness of Triple Therapy With Palonosetron for PON Prophylaxis
Postoperative Nausea and Vomiting
Primary: PONV Incidence — 12 participants
N/A N=115 Comparison of Aprepitant Versus Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting
Nausea · Vomiting
Primary: Number of Participants With Nausea and Vomiting — 24; 29 participants
Phase 4 N=98 Antiemetic Prophylaxis for Postdischarge Nausea and Vomiting After Hip Arthroscopy
Nausea and Vomiting, Postoperative
Primary: Incidence of Nausea — 46; 54 percentage of participants
N/A N=115 Comparison of Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting
Nausea · Vomiting
Primary: Number of Participants With Postoperative Nausea and Vomiting — 28; 34 participants
N/A N=27,034 Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis
Postoperative Nausea and Vomiting
Primary: Adherence to PONV Guidelines — 666; 5260; 5863 Participants
N/A N=84 Guanfacine for PONV and Pain After Sinus Surgery
Postoperative Nausea and Vomiting · Pain, Postoperative
Primary: Comparison of PONV Score of Assessments Done at 15 Minutes After Arrival in PACU Using 11-point Nausea Scale (nVRS) — 35; 33; 1; 2 Participants
Phase 4 N=83 Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy
Post-operative Nausea and Vomiting · Laparoscopic Sleeve Gastrectomy
Primary: Number of Participants With PONV-related Delay of Hospital Discharge — 0; 4 Participants
N/A N=55 Post- Surgery Recovery: Nerve Blocks w/ Sedation vs. Nerve Block w/ Either Sedation/Gen. Anesthesia
Nausea · Emesis
Primary: Number of Participants With Nausea 1 Hour After Post-anesthesia Care Unit (PACU) Admission — 1; 0; 1; 14 Participants
Phase 4 N=56 B&O for TLH Post-operative Pain and Nausea
Hysterectomy · Pain, Postoperative
Primary: Post-operative Pain: VAS — 4.1; 4.8 score on a scale — p=0.17
Phase 2 N=257 Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV)
Postoperative Nausea and Vomiting
Primary: Experienced Post-operative Nausea or Vomiting — 25; 29; 20; 30 participants
Phase 2 N=50 Granisetron Transdermal Patch for Prevention of Postoperative Nausea and Vomiting
Postoperative Nausea and Vomiting
Primary: Number of Participants With Complete Response (CR), No PONV Symptoms, Nausea — 8; 25; 24; 28 Participants
N/A N=160 Effect of Intraoperative Crystalloid Volume on Postoperative Vomiting
Postoperative Vomiting
Primary: Postoperative Vomiting — 11; 9; 66; 68 participants — p=0.05
Phase 4 N=141 Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting
Post-operative Nausea and Vomiting
Primary: Nausea Scale — 3.5; 4.0; 4.0; 2.0 score on a scale
N/A N=200 Accupressure of P6 to Reduce Nausea During Cesarean Section
Pregnancy Related · Cesarean Delivery · Nausea
Primary: Presence of Intraoperative Vomiting — 17; 17 Participants — p=.94
Phase 3 N=670 Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients
Postoperative Nausea and Vomiting
Primary: Proportion of Patients With Complete Response — 78.2; 82.7 percentage of patients
Phase 4 N=121 Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting
Postoperative Nausea and Vomiting (PONV) · Nausea
Primary: Proportion of Patients With a Complete Response/Complete Control During the First 24 Hours After Neurological Surgery Under General Anesthesia — 38; 41; 30; 30…
Phase 4 N=124 Effect of Intraoperative Anesthetic Management on Postoperative Nausea and Vomiting in Bariatric Surgery
Postoperative Nausea and Vomiting
Primary: PONV During the First 24 Hours After Bariatric Surgery — 22; 12 participants — p=0.04
N/A N=100 Reletex Versus Standard of Care Therapy for Post-Operative Nausea Control in Patients Undergoing Foregut Surgery
Nausea and Vomiting Post-foregut Surgery
Primary: Comparison of Postoperative Nausea and Vomiting Scores Between Groups Treated With a ReletexTM Device and Those Without the Device. — 1.81; 2.03 units on a scale
N/A N=122 The Effect of Electroacustimulation on Postoperative Nausea, Vomiting and Pain in Outpatient Plastic Surgery Patients
Postoperative Nausea and Vomiting
Primary: Post-operative Nausea Scores — NA; NA; NA; NA participants
Phase 3 N=150 Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients
Postoperative Nausea and Vomiting
Primary: Proportion of Patients With no Emetic Episodes in the Overall Time Period 0-72 Hours Post-operatively — 88.0; 84.0 percentage of patients
Phase 2 N=215 Phase II Dose-ranging Study of APD421 in PONV
Postoperative Nausea and Vomiting
Primary: Post-operative Nausea or Vomiting — 37; 28; 20; 30 participants
Phase 3 N=216 A Study to Examine the Safety and Tolerability of MK0517 for the Prevention of Post-Operative Nausea and Vomiting (0517-015)
Post-Operative Nausea and Vomiting
Primary: Number of Patients With Clinical Adverse Experiences (CAEs) — 125; 32 Participants
N/A N=233 Study of Anesthesia Techniques to Reduce Nausea and Vomiting After Jaw Corrective Surgery
Post-operative Nausea · Post-operative Vomiting · Nausea Persistent
Primary: Post-operative Nausea — 24; 70 percentage of subjects with PON
N/A N=150 Optimal Haloperidol Dose for Postoperative Nausea and Vomiting Prevention in High-risk Patients
Gynecological Disease
Primary: Incidence of Postoperative Nausea and Vomiting — 21; 11; 10 participants
Phase 4 N=150 Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery
Postoperative Nausea and Vomiting
Primary: Number of Participants Having Post-operative Emesis and Nausea. — 7; 22 participants — p=<0.05
N/A N=62 Study of the Effect of the Drug Gabapentin on Postoperative Pain and Incidence of Postoperative Nausea and Vomiting
Obesity, Morbid · Postoperative Pain · Postoperative Nausea and Vomiting
Primary: Evaluate the Amount of Diluadid Given Postoperatively — 11.035; 8.7; 12.4 ml
Phase 3 N=239 Efficacy of Ginger on Intraoperative and Postoperative Nausea and Vomiting in Elective Cesarean Section Patients
Nausea · Vomiting
Primary: Occurrence of Intra-operative and Post-operative Vomiting — 30; 45 Participants — p=0.07